PRICE T ROWE ASSOCIATES INC /MD/

Position in FTRE — Fortrea Holdings Inc.

CIK 80255 BALTIMORE, MD

Position in FTRE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,166,374

-$782,600 QoQ

Shares Held

123,819

+9.6% QoQ

Ownership

0.131%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. FTRE ranks #154 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	3,374,955	$2,464,560,888
2	REGN	Regeneron Pharmaceuticals, Inc.	2,177,527	$1,682,444,460
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,760,122	$785,964,877
4	INSM	INSMED Inc	3,092,807	$505,735,799
5	KYMR	Kymera Therapeutics, Inc.	6,060,847	$504,807,946
6	ALNY	Alnylam Pharmaceuticals, Inc.	1,432,748	$474,053,330
7	ASND	Ascendis Pharma A/S	1,530,345	$350,035,811
8	RVMD	Revolution Medicines, Inc.	3,232,213	$314,332,713

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,166,374	123,819	+9.6%	Shares	Defined	2026-05-15
2025-12-31	$1,948,974	112,984	+22.2%	Shares	Defined	2026-02-17
2025-09-30	$778,597	92,470	+16.8%	Shares	Defined	2025-11-14
2025-06-30	$391,055	79,161	+20.9%	Shares	Defined	2025-08-14
2025-03-31	$494,426	65,487	+9.8%	Shares	Defined	2025-05-14
2024-12-31	$1,112,099	59,630	+7.7%	Shares	Defined	2025-02-14
2024-09-30	$1,107,400	55,370	+5.6%	Shares	Defined	2024-11-14
2024-06-30	$1,224,066	52,445	+3.8%	Shares	Defined	2024-08-14
2024-03-31	$2,028,314	50,531	+5.7%	Shares	Defined	2024-05-15
2023-12-31	$1,668,220	47,800	+3.8%	Shares	Defined	2024-02-16
2023-09-30	$1,316,712	46,055	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.